2004
  1. Blaber,S.I., Ciric,B., Christophi,G.P., Bernett,M.J., Blaber,M., Rodriguez,M. and Scarisbrick,I.A.
    Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease
    FASEB J18, 920-922. PubMed  Europe PubMed DOI